The American Institute of Thermography and Diagnostics EARLY DETECTION IS ‘Prevention at its best’

Research


Study Faults Breast Cancer Exams (Los Angeles Times Posted on November 27, 2012).


The Los Angeles Times reports that about one-third of all tumors discovered in routine


mammography screenings are unlikely to result in illness, according to a study published


in the New England Journal of Medicine. The study, co-authored by H. Gilbert Welch,


a professor of medicine at The Dartmouth Institute for Health Policies and


Clinical Practice, says that go years of the breast cancer exams have resulted


in the over-diagnosis of 3 million American women, the newspaper reports.


"Our study raises serious questions about the value of screening mammography,"


Welch writes in the study. "It clarifies that the benefit of mortality reduction


is probably smaller, and the harm of over-diagnosis probably larger, than has


been previously recognized."



New England Journal of Medicine By Andrew M Kaunitz, MD December 30, 2012


New Analysis fails to identify clear net benefit of screening. We have become


increasingly aware of the potential harms of screening mammography,


while cognizant that much of the reduction in breast cancer mortality reflects advances


in treatment. To clearly communicate the relative benefits and risks associated with the


Screening mammography, investigators used study data from Sweden, Canada and the


U.S. to quantify the likelihood of three outcomes in women aged 40,50,60; reduction


in breast cancer mortality, false positive results and over diagnosis of in situ and invasive


breast cancer. The authors estimate that among 1000 women aged 50 who undergo


annual screening for I decade, 0.3 to 3.2 fewer deaths from breast cancer will occur,


490 to 670 women will receive at least I false positive finding and 3 to 14 women will be over diagnosed


(usually leading to unnecessary treatment). Comment from Welch HG and Passow HJ Intern Med.


Simply knowing that mammographic screening involves risks and benefits is not enough;


making informed choices about screening involves the ability to weigh these risks and benefits.


These authors acknowledge that, while the estimated outcomes ranges they have calculated might not


help all women to make informed decisions, providing a single "best" estimate could be misleading. We should keep


in mind that the this practice started over 50 years ago and it could well be time to rigorously reevaluate


this practice.



There's also a Dr. Oz connection and a screening theme in Jane Brody's New York Times column,


"Thyroid Fears Aside, That X-Ray's Worth It." Excerpt: "It doesn't take much to scare people when


it comes to cancer, especially when the cause, unlike smoking, seems beyond one's control. So I was not surprised


by a stream of panicked e-mails I received after a television show in which the popular Dr. Mehmet Oz called


thyroid cancer "the fastest-growing cancer in women" and cited the harmful effects of radiation from sources


like dental X-rays and mammograms. ... Dr. Otis W. Brawley, chief medical officer of the American Cancer Society,


said the stable death rate despite a rising incidence strongly suggests that most of the thyroid cancers now being


diagnosed would never have become a health threat. "Our technology has gotten so good that we are finding


cancers today that even 15 years ago would not have been diagnosed," Dr. Brawley said in an interview.


"We're finding and treating cancers that would never have killed anyone." In a study describing a 140 percent


increase in thyroid cancers diagnoses from 1973 to 2002, published in The Journal of the American Medical


Association in 2006, researchers at the Veterans Affairs medical center in White River Junction, Vt., Also


concluded that the rise was the result of "increased diagnostic scrutiny."